Links to other pages within Patient UK which are related to this topic:
Experience | Patient+ | News | Products | Other
Print options:   Other options:   (what's this?)

This is a PatientPlus article. PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

Langerhans Cell Histiocytosis

Also known as Histiocytosis X, LCH

Background

The name Langerhans cell histiocytosis has superseded Histiocytosis X as it indicates the origin of the cells rather than suggesting an unknown quantity. It is a group of idiopathic diseases involving proliferation of Langerhans cells from bone marrow and mature eosinophils. There is some debate as to whether it is truly a malignant or a reactive disorder. The disease has been reclassified in recent years.1

Histiocytosis is divided into 3 different groups:

  • Dendritic cell histiocytosis
  • Erythrophagocytic macrophage disorders
  • Malignant histiocytosis

Langerhans cell histiocytosis is part of the group of dendritic cell histiocytosis and is further divided into 3 different groups:

  • Eosinophilic granuloma is an indolent variety. Lesions of bones and other organs are few and chronic.
  • Hand-Schuller-Christian disease is multifocal and chronic. The classical presentation is as the triad of diabetes insipidus, proptosis, and lytic bone lesions.
    • There is also a congenital, self-healing form called Hashimoto-Pritzker disease that presents soon after birth.2
  • Letterer-Siwe disease is an acute and fulminant disease of great malignancy with very poor prognosis.
Epidemiology

It is a rare condition affecting between about 0.5 and 5 people per million per year. It tends to affect white races more often. Boys are affected about twice as often as girls.

  • Letterer-Siwe disease occurs mostly in children under 2.
  • The chronic multifocal form, including Hand-Schuller-Christian syndrome, occurs most often between 2 and 10 years.
  • Localized eosinophilic granuloma tends to affect those between 5 and 15 years.
  • LCH is uncommon in adults and rare in the elderly but has been reported.3
History

Presentation depends upon the extent of the disease. In multifocal disease presentation will depend upon the site and organ affected.

  • Unifocal disease usually presents as a lytic lesion of bone that is found incidentally. It can affect any bone but the hands and feet are less commonly involved.
  • Hand-Schuller-Christian syndrome occurs in 25% of patients with multifocal disease. It often presents with recurrent episodes of otitis media and mastoiditis due to erosion of the temporal and mastoid bones or with polyuria and polydypsia from diabetes insipidus.
  • Letterer-Siwe disease presents with symptoms suggestive of a systemic infection or malignancy with widespread skin eruption, anaemia, hepatomegaly and splenomegaly. Patients with pulmonary involvement present with chest pain, haemoptysis, dyspnoea, failure to thrive, cystic changes, and pneumothorax. Neurological features include seizures, vertigo, headache, ataxia, and cognitive defects.
  • The congenital form of LCH presents as skin lesions at birth or in the early postnatal period. There are cutaneous nodules and ulceration or possibly symptoms of organ involvement.
  • In a study from America, 63% of children presented with problems of the head and neck and over 80% developed problems of the head and neck at some time.4
Examination

Physical findings are also variable and will depend upon the site and degree of involvement. Lesions may affect the liver (20%), the spleen (30%), and the lymph nodes (50%). Lungs and bones may be affected and there may be mucocutaneous lesions. Skin lesions are often the first sign.

Eosinophilic Granuloma

  • It may present as a solitary lesion on the crown of the head. Other common sites include vertebrae, ribs, mandible, femur, ilium, and scapula. They are usually asymptomatic, but bone pain and a soft tissue mass may occur.
  • If a lesion of the skull extends into the brain it can produce neurological signs.
  • Proptosis can result from orbital masses, loose teeth from infiltration of the mandible and pituitary inadequacy from involvement of the sella turcica.
  • Osteolytic lesions can cause fracture of long bones or vertebral collapse
  • Skin disease presents with nodular or ulcerative lesions of the mouth, perineal, perivulvar or retroauricular regions.
  • When adults are affected, pulmonary lesions may be the only feature.

Hand-Schuller-Christian Syndrome

See separate article Hand-Schuller-Christian Syndrome.

  • Lesions will cause enlargement of the liver in 20%, spleen in 30% and lymph nodes in 50%.
  • Osteolytic lesions of long bones cause pathological fractures.
  • There may be signs in the chest.
  • Around 30% have lesions of skin and mucous membranes. They are infiltrated nodules and ulcerated plaques, usually in the mouth, the axillae, and the anogenital region.

Letterer-Siwe Disease

  • Skin lesions are often the presenting feature. 80% have extensive eruptions on the scalp, face, trunk, buttocks and groin with possibly secondary infection.
  • Fever, anaemia and thrombocytopenia are common.
  • Pulmonary infiltration may occur.
  • Hepatosplenomegaly is typical.

Congenital Self Healing

  • Congenital self-healing histiocytosis presents at birth or soon after with firm, red-brown, painless, papules about 1 to 10 mm in diameter or vesicles and crusts.
  • They involve the scalp, face, and to a lesser extent, the trunk and the extremities.
  • Ulceration may occur.
Investigation
  • FBC with differential white count, reticulocyte count, ESR, direct and indirect Coombs test and immunoglobulin levels. Coagulation studies.
  • If there is anaemia, leukopenia, or thrombocytopenia, bone marrow aspiration is required.
  • Thrombocytopenia and raised ESR are good indicators of disease activity.5
  • If there are abnormal LFTs, liver biopsy may be required to differentiate from causes of cirrhosis.
  • If diabetes insipidus is suspected, urine osmolarity is required after overnight depletion. It may not be present at presentation but develop over the years to affect up to a quarter.6
  • CXR may show micronodular and interstitial infiltrate in the mid zone and base of the lung, with sparing of the costophrenic angles. Older lesions show a honeycomb appearance.
  • Skeletal survey may show isolated or multiple lytic lesions.
  • MRI scan or CT scan of the hypothalamic-pituitary region.
  • Hormonal studies of the hypothalamic-pituitary axis. There may well be partial or complete hypopituitarism, especially growth hormone.7
  • Biopsy of skin lesions
Management

Management and also prognosis will depend upon the extent of the disease. There may be a single bone involved or several. There may be single or multiple lymph node involvement.

Single System Disease

  • Single bone lesions need curettage or excision. Painful sites may require intralesional injection of steroid. Large lesions may merit radiotherapy.
  • Multiple bone lesions are best treated with indomethacin or a short course of systemic steroids. It is uncertain if indomethacin has a specific action on the disease or simply acts as an analgesic.8
  • Skin lesions are usually treated with moderate to potent steroid creams but severe cases may need topical nitrogen mustard (20% solution). Psoralen plus ultraviolet A (PUVA) is sometimes used.9
  • Single lymph nodes can be excised but multiple nodes require a course of steroids.

Multi-system Disease

  • Chemotherapy is required for multisystem disease or single system disease that does not respond to the above treatment. Methotrexate, prednisolone, and vinblastine are used, usually in quite moderate doses.
  • In difficult cases a combination of cyclosporin A, antithymocyte globulin and prednisolone may be used.
  • Bone marrow transplantation represents the ultimate step if a suitable donor can be found.
  • A specific problem such as diabetes insipidus requires desmopressin.
Complications
  • Between 30 and 50% of patients with LCD suffer complications.
  • The commonest are orthopaedic disabilities, hearing impairment, diabetes insipidus, and neuropsychological defects.
  • Less common are chronic pulmonary dysfunction, liver cirrhosis, and growth retardation.
Prognosis

This depends upon the type and extent of disease as well as response to treatment. Dysfunction of organs has a poor prognosis.

  • For a single focus of disease prognosis is excellent. If no additional lesions present after a year it is unlikely that more will arise. There is usually full recovery from solitary lymph node involvement or isolated skin disease.
  • With multi-focal disease 60% have a chronic course, 30% achieve remission and 10% die.
  • Letterer-Siwe disease has a mortality of 50% and this is worse in the very young.
  • The congenital form of histiocytosis tends to resolve spontaneously within weeks to months.
  • A study of 60 children who had survived LCH was reported in 1980. In those whose disease involved soft tissue and bone 50% had severe disabilities. Treatment may have improved since then but such figures are cause for concern.10
  • A review from 1999 concluded that patients with isolated bone lesions have the best prognosis compared with involvement of other systems. 20% of patients with multisystem involvement have a progressive disease course despite treatment. The identification of prognostic indicators to facilitate appropriate treatment and long term follow-up surveillance is recommended.11
Biographical Note

Paul Langerhans was born in Berlin in 1847. He graduated MD in 1869 and worked as a pathological anatomist. He also described the Islets of Langerhans that produce insulin. In 1874 pulmonary tuberculosis interrupted his career and the next year he moved to Madeira for a milder climate to ease his disease. He died there in 1888.12


Document references
  1. Favara BE, Feller AC, Pauli M, et al; Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol. 1997 Sep;29(3):157-66. [abstract]
  2. Larralde M, Rositto A, Giardelli M, et al; Congenital self-healing histiocytosis (Hashimoto-Pritzker). Int J Dermatol. 1999 Sep;38(9):693-6. [abstract]
  3. Gerlach B, Stein A, Fischer R, et al; Langerhans cell histiocytosis in the elderly. Hautarzt. 1998 Jan;49(1):23-30. [abstract]
  4. DiNardo LJ, Wetmore RF; Head and neck manifestations of histiocytosis-X in children. Laryngoscope. 1989 Jul;99(7 Pt 1):721-4. [abstract]
  5. Calming U, Henter JI; Elevated erythrocyte sedimentation rate and thrombocytosis as possible indicators of active disease in Langerhans' cell histiocytosis. Acta Paediatr. 1998 Oct;87(10):1085-7. [abstract]
  6. Dunger DB, Broadbent V, Yeoman E, et al; The frequency and natural history of diabetes insipidus in children with Langerhans-cell histiocytosis. N Engl J Med. 1989 Oct 26;321(17):1157-62. [abstract]
  7. Lin KD, Lin JD, Hsu HH, et al; Endocrinological aspects of Langerhans cell histiocytosis complicated with diabetes insipidus. J Endocrinol Invest. 1998 Jul-Aug;21(7):428-33. [abstract]
  8. Munn SE, Olliver L, Broadbent V, et al; Use of indomethacin in Langerhans cell histiocytosis. Med Pediatr Oncol. 1999 Apr;32(4):247-9. [abstract]
  9. Kwon OS, Cho KH, Song KY; Primary cutaneous Langerhans cell histiocytosis treated with photochemotherapy. J Dermatol. 1997 Jan;24(1):54-6. [abstract]
  10. Komp DM, El Mahdi A, Starling KA, et al; Quality of survival in histiocytosis X: a Southwest Oncology Group study. Med Pediatr Oncol. 1980;8(1):35-40. [abstract]
  11. Howarth DM, Gilchrist GS, Mullan BP, et al; Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome. Cancer. 1999 May 15;85(10):2278-90. [abstract]
  12. whonamedit.com; Paul Langerhans; Brief biography.

Internet and further reading Acknowledgements EMIS is grateful to the Mentor authoring team for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2009.
DocID: 2369
Document Version: 21
DocRef: bgp2781
Last Updated: 24 Apr 2007
Review Date: 23 Apr 2009

The authors and editors of this article are employed to create accurate and up to date content reflecting reliable research evidence, guidance and best clinical practice. They are free from any commercial conflicts of interest.

Find out more about updating.

(what's this?)

Patient UK Current Health News

Advertisements




Patient News







Disclaimer: Patient UK has no control over the content of any external links above. Inclusion does not imply endorsement by Patient UK.

Want to advertise on this site? Find out how >>

Clicking here will take you to the foot of this page where you'll find a list of Information Leaflets which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Support Groups which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Medicines & Drugs which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of diagrams which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of PatientPlus (detailed reference) articles which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of UK Guidelines which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of other selected websites which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Poems and Stories which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Operations and Procedures which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Online Videos which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find links through to our interactive forum.
Here you can follow a link to view existing patient experiences on this subject, or to add your own
Clicking here will take you to the foot of this page where you'll find links to news stories on this subject in our Online Newspaper
Clicking here will take you to the foot of this page where you'll find links to related products
Clicking here will take you to the foot of this page where you'll find links to other useful sources of information
Click here to open a printer-friendly version of this document, in a new window, together with the print dialogue box
Click here to open this document in PDF format
This will offer you the usual PDF options i.e. document navigation, search, zoom and formatted print
Note: this is the best way to print the document
Click here to listen to the MP3 audio recording of this document
Click here to download the audio recording of this document as a podcast, for listening to at your leisure
Click here to open our Dictionaries and Glossaries page
Click here to see related products in our Online Pharmacy
Note: this will open in a new window
Click here to add this page to a social bookmarking site of your choice
Click here if you want to find out more about social bookmarking. This link will take you to the Wikipedia explanation
Note: this will open in a new window
Click here to return to the home page
Click here to read our 'About Us' page
Go to the Emis Access website, where you can book an appointment with your GP, order a repeat prescription or view you medical record online.
Note: this will open in a new window
View and/or join in discussion about health, lifestyle and disease in our interactive forum.
Note: this will open in a new window
Go to our online pharmacy where you can buy over-the-counter products for home delivery.
Note: this will open in a new window
Go to our online newspaper for current medical news and commentary.
Note: this will open in a new window
Adverts on this site do not influence the medical content. Click to read more.
Adverts on this site do not influence the medical content. Click to read more.